Ashit Trivedi

614 total citations
29 papers, 316 citations indexed

About

Ashit Trivedi is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, Ashit Trivedi has authored 29 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in Ashit Trivedi's work include Heart Failure Treatment and Management (13 papers), Cardiac pacing and defibrillation studies (10 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Ashit Trivedi is often cited by papers focused on Heart Failure Treatment and Management (13 papers), Cardiac pacing and defibrillation studies (10 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Ashit Trivedi collaborates with scholars based in United States, Japan and Germany. Ashit Trivedi's co-authors include Partha Karmakar, Bernd Meibohm, Richard Lee, Stephanie Faucette, Siddique Abbasi, Neeraj Gupta, Karthik Venkatakrishnan, Edward Lee, John P. Gibbs and Sandeep Dutta and has published in prestigious journals such as Frontiers in Microbiology, Clinical Pharmacokinetics and Bioorganic & Medicinal Chemistry.

In The Last Decade

Ashit Trivedi

27 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashit Trivedi United States 9 114 64 54 53 40 29 316
Lucette Doessegger Switzerland 8 108 0.9× 44 0.7× 35 0.6× 62 1.2× 35 0.9× 12 340
Martin W. James United Kingdom 9 51 0.4× 23 0.4× 44 0.8× 21 0.4× 69 1.7× 14 542
Ayahisa Watanabe Japan 11 221 1.9× 31 0.5× 39 0.7× 18 0.3× 22 0.6× 32 368
Trevor T. Charvat United States 9 85 0.7× 63 1.0× 43 0.8× 99 1.9× 8 0.2× 10 421
Xinyu Huang China 12 143 1.3× 21 0.3× 13 0.2× 25 0.5× 23 0.6× 39 450
Bas Thijssen Netherlands 12 138 1.2× 205 3.2× 55 1.0× 11 0.2× 21 0.5× 21 461
Sijia Yu China 12 222 1.9× 91 1.4× 12 0.2× 57 1.1× 13 0.3× 40 473
Jiecan Zhou China 10 145 1.3× 34 0.5× 23 0.4× 45 0.8× 16 0.4× 34 442
N. D’Alessandro Italy 11 161 1.4× 157 2.5× 21 0.4× 49 0.9× 20 0.5× 33 502

Countries citing papers authored by Ashit Trivedi

Since Specialization
Citations

This map shows the geographic impact of Ashit Trivedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashit Trivedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashit Trivedi more than expected).

Fields of papers citing papers by Ashit Trivedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashit Trivedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashit Trivedi. The network helps show where Ashit Trivedi may publish in the future.

Co-authorship network of co-authors of Ashit Trivedi

This figure shows the co-authorship network connecting the top 25 collaborators of Ashit Trivedi. A scholar is included among the top collaborators of Ashit Trivedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashit Trivedi. Ashit Trivedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miao, Shichang, et al.. (2024). Food Effect and Pharmacokinetic Bridging of Avacopan in Caucasian and Japanese Healthy Participants. Clinical Pharmacology in Drug Development. 13(9). 1011–1023. 2 indexed citations
2.
3.
Miao, Shichang, Pirow Bekker, Danielle Armas, et al.. (2024). Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants. Clinical Pharmacology in Drug Development. 13(5). 517–533. 7 indexed citations
4.
5.
6.
Trivedi, Ashit, et al.. (2022). Effect of Severe Renal Impairment on the Safety, Tolerability, and Pharmacokinetics of AMG 986. Drugs in R&D. 22(1). 89–94. 4 indexed citations
7.
Chen, Po‐Wei, Ashit Trivedi, Edward Lee, Sandeep Dutta, & Malidi Ahamadi. (2022). Population Pharmacokinetic Properties of Omecamtiv Mecarbil in Healthy Subjects and Patients With Heart Failure With Reduced Ejection Fraction. Journal of Cardiovascular Pharmacology. 79(4). 539–548.
8.
Winkle, Peter, Steven R. Goldsmith, Michael J. Koren, et al.. (2022). A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients. Cardiovascular Drugs and Therapy. 37(4). 743–755. 16 indexed citations
9.
Trivedi, Ashit, Fady I. Malik, Makoto Aoki, et al.. (2021). Pharmacokinetics, Tolerability, and Safety of Single and Multiple Omecamtiv Mecarbil Doses in Healthy Japanese and Caucasian Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 46(6). 759–770.
10.
Trivedi, Ashit, Rajneet K. Oberoi, Pegah Jafarinasabian, et al.. (2021). Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil. Clinical Pharmacology in Drug Development. 10(12). 1442–1451. 4 indexed citations
11.
Trivedi, Ashit, et al.. (2021). Pharmacokinetics, Disposition, and Biotransformation of [14C]Omecamtiv Mecarbil in Healthy Male Subjects after a Single Intravenous or Oral Dose. Drug Metabolism and Disposition. 49(8). 619–628. 7 indexed citations
12.
Trivedi, Ashit, Rajneet K. Oberoi, Pegah Jafarinasabian, et al.. (2021). Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects. Clinical Drug Investigation. 41(7). 647–652. 2 indexed citations
13.
Trivedi, Ashit, Rajneet K. Oberoi, Pegah Jafarinasabian, et al.. (2021). Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil. Clinical Pharmacokinetics. 60(8). 1041–1048. 11 indexed citations
14.
Trivedi, Ashit, Fady I. Malik, Pegah Jafarinasabian, et al.. (2021). Pharmacokinetic Evaluation of the CYP3A4 and CYP2D6 Drug‐Drug Interaction and CYP3A4 Induction Potential of Omecamtiv Mecarbil: Two Open‐Label Studies in Healthy Subjects. Clinical Pharmacology in Drug Development. 11(2). 185–193. 4 indexed citations
15.
Jackson, Mary, Ashit Trivedi, Fernando R. Pavan, et al.. (2018). Primary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular Mycobacterium tuberculosis. Frontiers in Microbiology. 9. 1895–1895. 6 indexed citations
16.
Vaddady, Pavan, Ashit Trivedi, Chetan Rathi, et al.. (2018). Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis. European Journal of Pharmaceutical Sciences. 127. 233–239. 9 indexed citations
17.
Trivedi, Ashit, Sabine Stienen, Min Zhu, et al.. (2017). Clinical Pharmacology and Translational Aspects of Bispecific Antibodies. Clinical and Translational Science. 10(3). 147–162. 57 indexed citations
18.
Trivedi, Ashit, Jiuyu Liu, Vincent A. Boyd, et al.. (2016). Tissue Penetration of a Novel Spectinamide Antibiotic for the Treatment of Tuberculosis. The AAPS Journal. 18(3). 788–791. 4 indexed citations
19.
Trivedi, Ashit, Richard Lee, & Bernd Meibohm. (2013). Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives. Expert Review of Clinical Pharmacology. 6(2). 159–170. 20 indexed citations
20.
Rakesh, Rakesh, David F. Bruhn, Marcus M. Maddox, et al.. (2012). Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry. 20(20). 6063–6072. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucette Doessegger Breakdown of academic impact, for papers by Martin W. James Breakdown of academic impact, for papers by Ayahisa Watanabe Breakdown of academic impact, for papers by Trevor T. Charvat Breakdown of academic impact, for papers by Xinyu Huang Breakdown of academic impact, for papers by Bas Thijssen Breakdown of academic impact, for papers by Sijia Yu Breakdown of academic impact, for papers by Jiecan Zhou Breakdown of academic impact, for papers by N. D’Alessandro
Rankless by CCL
2026